Our team also promotes wide collaboration on research studies examining the trajectories of ESKD and CKD, including risk factors for hospitalization and cardiovascular outcomes, risk prediction modeling, transition of care in CKD (TCCKD), and treatment pathways (e.g., dialysis, conservative management). Ongoing and completed collaborative studies include:
Ongoing collaborations
2019-2024: A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
R01 DK122767, PI Connie Rhee, NIH/NIDDK), Website: hdthyroid.com
2020-2025: Defining Optimal Transitions of Care in Advanced Kidney Disease: Conservative Management vs. Dialysis Approaches
R01 DK124138, contact PI Connie Rhee, NIH/NIDDK
2023-2026: Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia (CONDOR Trial)
R01 DK132869, contact PI Connie Rhee, NIH/NIDDK
Completed collaborations
2011-2021: Malnutrition, Diet and Racial Disparities in Chronic Kidney Disease
K24 DK091419, PI Kam Kalantar-Zadeh, NIH/NIDDK
2018-2021: Novel Saliva-based Renal Function Test Platform
R44 DK116383, contact PI Beshay M, NIH/NIDDK
2014-2020: Transition of Care in CKD, United Stated Renal Data System (USRDS) Special Study Center
U01-DK102163, mPIs Kalantar-Zadeh, Kovesdy, Jacobsen, NIH/NIDDK
2014-2019: Hypothyroidism, Cardiovascular Health, and Survival in Kidney Disease
K23 DK102903, PI Connie Rhee, NIH/NIDDK
2017-2019: A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
R03 DK114642, PI Connie Rhee, NIH/NIDDK
2013-2015: Comparative Effectiveness of Home Hemodialysis versus Kidney Transplantation in the Elderly
R21AG047036, mPIs Molnar M, Kalantar-Zadeh K, NIH/NIA/NINR
2012-2015: Infection in Dialysis Patients: Risk Factors and Outcomes
K23 DK093584, PI Dalrymple LS, NIH/NIDDK
2016-2017: High Risks Periods During the Course of Dialysis
DCI-201601988, PI Dalrymple LS, Dialysis Clinic Inc.